Medical Care
Global Antiviral Drug Resistance Market Research Report 2024
- Apr 15, 24
- ID: 168846
- Pages: 81
- Figures: 165
- Views: 18
Antiviral drug resistance refers to decreased susceptibility towards a drug which occurs due to changes in viral genotypes. During instances of antiviral resistance, the drugs have either lost their effectiveness or have been diminished against the virus to be targeted. Antiviral drug resistance is a rising concern among the immune-compromised patients.
The global Antiviral Drug Resistance market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antiviral Drug Resistance, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Drug Resistance.
Report Scope
The Antiviral Drug Resistance market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiviral Drug Resistance market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiviral Drug Resistance companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AccuBioTech Co., Ltd.
ACON Laboratories, Inc.
Siemens AG
BioMerieux SA
Bio-Rad Laboratories, Inc.
Danaher
Abbott
BD
F. Hoffmann-La Roche Ltd.
Trinity Biotech
Segment by Type
Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Sanger Sequencing
Other Technologies
Segment by Application
Hospitals & Clinics
Pathology or Diagnostic Laboratories
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiviral Drug Resistance companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Antiviral Drug Resistance market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antiviral Drug Resistance, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Drug Resistance.
Report Scope
The Antiviral Drug Resistance market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiviral Drug Resistance market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiviral Drug Resistance companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AccuBioTech Co., Ltd.
ACON Laboratories, Inc.
Siemens AG
BioMerieux SA
Bio-Rad Laboratories, Inc.
Danaher
Abbott
BD
F. Hoffmann-La Roche Ltd.
Trinity Biotech
Segment by Type
Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Sanger Sequencing
Other Technologies
Segment by Application
Hospitals & Clinics
Pathology or Diagnostic Laboratories
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiviral Drug Resistance companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiviral Drug Resistance Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunodiagnostics
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Next Generation Sequencing (NGS)
1.2.5 Sanger Sequencing
1.2.6 Other Technologies
1.3 Market by Application
1.3.1 Global Antiviral Drug Resistance Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals & Clinics
1.3.3 Pathology or Diagnostic Laboratories
1.3.4 Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiviral Drug Resistance Market Perspective (2019-2030)
2.2 Antiviral Drug Resistance Growth Trends by Region
2.2.1 Global Antiviral Drug Resistance Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antiviral Drug Resistance Historic Market Size by Region (2019-2024)
2.2.3 Antiviral Drug Resistance Forecasted Market Size by Region (2025-2030)
2.3 Antiviral Drug Resistance Market Dynamics
2.3.1 Antiviral Drug Resistance Industry Trends
2.3.2 Antiviral Drug Resistance Market Drivers
2.3.3 Antiviral Drug Resistance Market Challenges
2.3.4 Antiviral Drug Resistance Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiviral Drug Resistance Players by Revenue
3.1.1 Global Top Antiviral Drug Resistance Players by Revenue (2019-2024)
3.1.2 Global Antiviral Drug Resistance Revenue Market Share by Players (2019-2024)
3.2 Global Antiviral Drug Resistance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antiviral Drug Resistance Revenue
3.4 Global Antiviral Drug Resistance Market Concentration Ratio
3.4.1 Global Antiviral Drug Resistance Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiviral Drug Resistance Revenue in 2023
3.5 Antiviral Drug Resistance Key Players Head office and Area Served
3.6 Key Players Antiviral Drug Resistance Product Solution and Service
3.7 Date of Enter into Antiviral Drug Resistance Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiviral Drug Resistance Breakdown Data by Type
4.1 Global Antiviral Drug Resistance Historic Market Size by Type (2019-2024)
4.2 Global Antiviral Drug Resistance Forecasted Market Size by Type (2025-2030)
5 Antiviral Drug Resistance Breakdown Data by Application
5.1 Global Antiviral Drug Resistance Historic Market Size by Application (2019-2024)
5.2 Global Antiviral Drug Resistance Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antiviral Drug Resistance Market Size (2019-2030)
6.2 North America Antiviral Drug Resistance Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antiviral Drug Resistance Market Size by Country (2019-2024)
6.4 North America Antiviral Drug Resistance Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiviral Drug Resistance Market Size (2019-2030)
7.2 Europe Antiviral Drug Resistance Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antiviral Drug Resistance Market Size by Country (2019-2024)
7.4 Europe Antiviral Drug Resistance Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiviral Drug Resistance Market Size (2019-2030)
8.2 Asia-Pacific Antiviral Drug Resistance Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antiviral Drug Resistance Market Size by Region (2019-2024)
8.4 Asia-Pacific Antiviral Drug Resistance Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiviral Drug Resistance Market Size (2019-2030)
9.2 Latin America Antiviral Drug Resistance Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antiviral Drug Resistance Market Size by Country (2019-2024)
9.4 Latin America Antiviral Drug Resistance Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiviral Drug Resistance Market Size (2019-2030)
10.2 Middle East & Africa Antiviral Drug Resistance Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antiviral Drug Resistance Market Size by Country (2019-2024)
10.4 Middle East & Africa Antiviral Drug Resistance Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AccuBioTech Co., Ltd.
11.1.1 AccuBioTech Co., Ltd. Company Detail
11.1.2 AccuBioTech Co., Ltd. Business Overview
11.1.3 AccuBioTech Co., Ltd. Antiviral Drug Resistance Introduction
11.1.4 AccuBioTech Co., Ltd. Revenue in Antiviral Drug Resistance Business (2019-2024)
11.1.5 AccuBioTech Co., Ltd. Recent Development
11.2 ACON Laboratories, Inc.
11.2.1 ACON Laboratories, Inc. Company Detail
11.2.2 ACON Laboratories, Inc. Business Overview
11.2.3 ACON Laboratories, Inc. Antiviral Drug Resistance Introduction
11.2.4 ACON Laboratories, Inc. Revenue in Antiviral Drug Resistance Business (2019-2024)
11.2.5 ACON Laboratories, Inc. Recent Development
11.3 Siemens AG
11.3.1 Siemens AG Company Detail
11.3.2 Siemens AG Business Overview
11.3.3 Siemens AG Antiviral Drug Resistance Introduction
11.3.4 Siemens AG Revenue in Antiviral Drug Resistance Business (2019-2024)
11.3.5 Siemens AG Recent Development
11.4 BioMerieux SA
11.4.1 BioMerieux SA Company Detail
11.4.2 BioMerieux SA Business Overview
11.4.3 BioMerieux SA Antiviral Drug Resistance Introduction
11.4.4 BioMerieux SA Revenue in Antiviral Drug Resistance Business (2019-2024)
11.4.5 BioMerieux SA Recent Development
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Bio-Rad Laboratories, Inc. Company Detail
11.5.2 Bio-Rad Laboratories, Inc. Business Overview
11.5.3 Bio-Rad Laboratories, Inc. Antiviral Drug Resistance Introduction
11.5.4 Bio-Rad Laboratories, Inc. Revenue in Antiviral Drug Resistance Business (2019-2024)
11.5.5 Bio-Rad Laboratories, Inc. Recent Development
11.6 Danaher
11.6.1 Danaher Company Detail
11.6.2 Danaher Business Overview
11.6.3 Danaher Antiviral Drug Resistance Introduction
11.6.4 Danaher Revenue in Antiviral Drug Resistance Business (2019-2024)
11.6.5 Danaher Recent Development
11.7 Abbott
11.7.1 Abbott Company Detail
11.7.2 Abbott Business Overview
11.7.3 Abbott Antiviral Drug Resistance Introduction
11.7.4 Abbott Revenue in Antiviral Drug Resistance Business (2019-2024)
11.7.5 Abbott Recent Development
11.8 BD
11.8.1 BD Company Detail
11.8.2 BD Business Overview
11.8.3 BD Antiviral Drug Resistance Introduction
11.8.4 BD Revenue in Antiviral Drug Resistance Business (2019-2024)
11.8.5 BD Recent Development
11.9 F. Hoffmann-La Roche Ltd.
11.9.1 F. Hoffmann-La Roche Ltd. Company Detail
11.9.2 F. Hoffmann-La Roche Ltd. Business Overview
11.9.3 F. Hoffmann-La Roche Ltd. Antiviral Drug Resistance Introduction
11.9.4 F. Hoffmann-La Roche Ltd. Revenue in Antiviral Drug Resistance Business (2019-2024)
11.9.5 F. Hoffmann-La Roche Ltd. Recent Development
11.10 Trinity Biotech
11.10.1 Trinity Biotech Company Detail
11.10.2 Trinity Biotech Business Overview
11.10.3 Trinity Biotech Antiviral Drug Resistance Introduction
11.10.4 Trinity Biotech Revenue in Antiviral Drug Resistance Business (2019-2024)
11.10.5 Trinity Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiviral Drug Resistance Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunodiagnostics
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Next Generation Sequencing (NGS)
1.2.5 Sanger Sequencing
1.2.6 Other Technologies
1.3 Market by Application
1.3.1 Global Antiviral Drug Resistance Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals & Clinics
1.3.3 Pathology or Diagnostic Laboratories
1.3.4 Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiviral Drug Resistance Market Perspective (2019-2030)
2.2 Antiviral Drug Resistance Growth Trends by Region
2.2.1 Global Antiviral Drug Resistance Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antiviral Drug Resistance Historic Market Size by Region (2019-2024)
2.2.3 Antiviral Drug Resistance Forecasted Market Size by Region (2025-2030)
2.3 Antiviral Drug Resistance Market Dynamics
2.3.1 Antiviral Drug Resistance Industry Trends
2.3.2 Antiviral Drug Resistance Market Drivers
2.3.3 Antiviral Drug Resistance Market Challenges
2.3.4 Antiviral Drug Resistance Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiviral Drug Resistance Players by Revenue
3.1.1 Global Top Antiviral Drug Resistance Players by Revenue (2019-2024)
3.1.2 Global Antiviral Drug Resistance Revenue Market Share by Players (2019-2024)
3.2 Global Antiviral Drug Resistance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antiviral Drug Resistance Revenue
3.4 Global Antiviral Drug Resistance Market Concentration Ratio
3.4.1 Global Antiviral Drug Resistance Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiviral Drug Resistance Revenue in 2023
3.5 Antiviral Drug Resistance Key Players Head office and Area Served
3.6 Key Players Antiviral Drug Resistance Product Solution and Service
3.7 Date of Enter into Antiviral Drug Resistance Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiviral Drug Resistance Breakdown Data by Type
4.1 Global Antiviral Drug Resistance Historic Market Size by Type (2019-2024)
4.2 Global Antiviral Drug Resistance Forecasted Market Size by Type (2025-2030)
5 Antiviral Drug Resistance Breakdown Data by Application
5.1 Global Antiviral Drug Resistance Historic Market Size by Application (2019-2024)
5.2 Global Antiviral Drug Resistance Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antiviral Drug Resistance Market Size (2019-2030)
6.2 North America Antiviral Drug Resistance Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antiviral Drug Resistance Market Size by Country (2019-2024)
6.4 North America Antiviral Drug Resistance Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiviral Drug Resistance Market Size (2019-2030)
7.2 Europe Antiviral Drug Resistance Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antiviral Drug Resistance Market Size by Country (2019-2024)
7.4 Europe Antiviral Drug Resistance Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiviral Drug Resistance Market Size (2019-2030)
8.2 Asia-Pacific Antiviral Drug Resistance Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antiviral Drug Resistance Market Size by Region (2019-2024)
8.4 Asia-Pacific Antiviral Drug Resistance Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiviral Drug Resistance Market Size (2019-2030)
9.2 Latin America Antiviral Drug Resistance Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antiviral Drug Resistance Market Size by Country (2019-2024)
9.4 Latin America Antiviral Drug Resistance Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiviral Drug Resistance Market Size (2019-2030)
10.2 Middle East & Africa Antiviral Drug Resistance Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antiviral Drug Resistance Market Size by Country (2019-2024)
10.4 Middle East & Africa Antiviral Drug Resistance Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AccuBioTech Co., Ltd.
11.1.1 AccuBioTech Co., Ltd. Company Detail
11.1.2 AccuBioTech Co., Ltd. Business Overview
11.1.3 AccuBioTech Co., Ltd. Antiviral Drug Resistance Introduction
11.1.4 AccuBioTech Co., Ltd. Revenue in Antiviral Drug Resistance Business (2019-2024)
11.1.5 AccuBioTech Co., Ltd. Recent Development
11.2 ACON Laboratories, Inc.
11.2.1 ACON Laboratories, Inc. Company Detail
11.2.2 ACON Laboratories, Inc. Business Overview
11.2.3 ACON Laboratories, Inc. Antiviral Drug Resistance Introduction
11.2.4 ACON Laboratories, Inc. Revenue in Antiviral Drug Resistance Business (2019-2024)
11.2.5 ACON Laboratories, Inc. Recent Development
11.3 Siemens AG
11.3.1 Siemens AG Company Detail
11.3.2 Siemens AG Business Overview
11.3.3 Siemens AG Antiviral Drug Resistance Introduction
11.3.4 Siemens AG Revenue in Antiviral Drug Resistance Business (2019-2024)
11.3.5 Siemens AG Recent Development
11.4 BioMerieux SA
11.4.1 BioMerieux SA Company Detail
11.4.2 BioMerieux SA Business Overview
11.4.3 BioMerieux SA Antiviral Drug Resistance Introduction
11.4.4 BioMerieux SA Revenue in Antiviral Drug Resistance Business (2019-2024)
11.4.5 BioMerieux SA Recent Development
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Bio-Rad Laboratories, Inc. Company Detail
11.5.2 Bio-Rad Laboratories, Inc. Business Overview
11.5.3 Bio-Rad Laboratories, Inc. Antiviral Drug Resistance Introduction
11.5.4 Bio-Rad Laboratories, Inc. Revenue in Antiviral Drug Resistance Business (2019-2024)
11.5.5 Bio-Rad Laboratories, Inc. Recent Development
11.6 Danaher
11.6.1 Danaher Company Detail
11.6.2 Danaher Business Overview
11.6.3 Danaher Antiviral Drug Resistance Introduction
11.6.4 Danaher Revenue in Antiviral Drug Resistance Business (2019-2024)
11.6.5 Danaher Recent Development
11.7 Abbott
11.7.1 Abbott Company Detail
11.7.2 Abbott Business Overview
11.7.3 Abbott Antiviral Drug Resistance Introduction
11.7.4 Abbott Revenue in Antiviral Drug Resistance Business (2019-2024)
11.7.5 Abbott Recent Development
11.8 BD
11.8.1 BD Company Detail
11.8.2 BD Business Overview
11.8.3 BD Antiviral Drug Resistance Introduction
11.8.4 BD Revenue in Antiviral Drug Resistance Business (2019-2024)
11.8.5 BD Recent Development
11.9 F. Hoffmann-La Roche Ltd.
11.9.1 F. Hoffmann-La Roche Ltd. Company Detail
11.9.2 F. Hoffmann-La Roche Ltd. Business Overview
11.9.3 F. Hoffmann-La Roche Ltd. Antiviral Drug Resistance Introduction
11.9.4 F. Hoffmann-La Roche Ltd. Revenue in Antiviral Drug Resistance Business (2019-2024)
11.9.5 F. Hoffmann-La Roche Ltd. Recent Development
11.10 Trinity Biotech
11.10.1 Trinity Biotech Company Detail
11.10.2 Trinity Biotech Business Overview
11.10.3 Trinity Biotech Antiviral Drug Resistance Introduction
11.10.4 Trinity Biotech Revenue in Antiviral Drug Resistance Business (2019-2024)
11.10.5 Trinity Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Antiviral Drug Resistance Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Immunodiagnostics
Table 3. Key Players of Polymerase Chain Reaction (PCR)
Table 4. Key Players of Next Generation Sequencing (NGS)
Table 5. Key Players of Sanger Sequencing
Table 6. Key Players of Other Technologies
Table 7. Global Antiviral Drug Resistance Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Antiviral Drug Resistance Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Antiviral Drug Resistance Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Antiviral Drug Resistance Market Share by Region (2019-2024)
Table 11. Global Antiviral Drug Resistance Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Antiviral Drug Resistance Market Share by Region (2025-2030)
Table 13. Antiviral Drug Resistance Market Trends
Table 14. Antiviral Drug Resistance Market Drivers
Table 15. Antiviral Drug Resistance Market Challenges
Table 16. Antiviral Drug Resistance Market Restraints
Table 17. Global Antiviral Drug Resistance Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Antiviral Drug Resistance Market Share by Players (2019-2024)
Table 19. Global Top Antiviral Drug Resistance Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Drug Resistance as of 2023)
Table 20. Ranking of Global Top Antiviral Drug Resistance Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Antiviral Drug Resistance Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Antiviral Drug Resistance Product Solution and Service
Table 24. Date of Enter into Antiviral Drug Resistance Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Antiviral Drug Resistance Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Antiviral Drug Resistance Revenue Market Share by Type (2019-2024)
Table 28. Global Antiviral Drug Resistance Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Antiviral Drug Resistance Revenue Market Share by Type (2025-2030)
Table 30. Global Antiviral Drug Resistance Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Antiviral Drug Resistance Revenue Market Share by Application (2019-2024)
Table 32. Global Antiviral Drug Resistance Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Antiviral Drug Resistance Revenue Market Share by Application (2025-2030)
Table 34. North America Antiviral Drug Resistance Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Antiviral Drug Resistance Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Antiviral Drug Resistance Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Antiviral Drug Resistance Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Antiviral Drug Resistance Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Antiviral Drug Resistance Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Antiviral Drug Resistance Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Antiviral Drug Resistance Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Antiviral Drug Resistance Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Antiviral Drug Resistance Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Antiviral Drug Resistance Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Antiviral Drug Resistance Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Antiviral Drug Resistance Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Antiviral Drug Resistance Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Antiviral Drug Resistance Market Size by Country (2025-2030) & (US$ Million)
Table 49. AccuBioTech Co., Ltd. Company Detail
Table 50. AccuBioTech Co., Ltd. Business Overview
Table 51. AccuBioTech Co., Ltd. Antiviral Drug Resistance Product
Table 52. AccuBioTech Co., Ltd. Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 53. AccuBioTech Co., Ltd. Recent Development
Table 54. ACON Laboratories, Inc. Company Detail
Table 55. ACON Laboratories, Inc. Business Overview
Table 56. ACON Laboratories, Inc. Antiviral Drug Resistance Product
Table 57. ACON Laboratories, Inc. Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 58. ACON Laboratories, Inc. Recent Development
Table 59. Siemens AG Company Detail
Table 60. Siemens AG Business Overview
Table 61. Siemens AG Antiviral Drug Resistance Product
Table 62. Siemens AG Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 63. Siemens AG Recent Development
Table 64. BioMerieux SA Company Detail
Table 65. BioMerieux SA Business Overview
Table 66. BioMerieux SA Antiviral Drug Resistance Product
Table 67. BioMerieux SA Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 68. BioMerieux SA Recent Development
Table 69. Bio-Rad Laboratories, Inc. Company Detail
Table 70. Bio-Rad Laboratories, Inc. Business Overview
Table 71. Bio-Rad Laboratories, Inc. Antiviral Drug Resistance Product
Table 72. Bio-Rad Laboratories, Inc. Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 73. Bio-Rad Laboratories, Inc. Recent Development
Table 74. Danaher Company Detail
Table 75. Danaher Business Overview
Table 76. Danaher Antiviral Drug Resistance Product
Table 77. Danaher Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 78. Danaher Recent Development
Table 79. Abbott Company Detail
Table 80. Abbott Business Overview
Table 81. Abbott Antiviral Drug Resistance Product
Table 82. Abbott Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 83. Abbott Recent Development
Table 84. BD Company Detail
Table 85. BD Business Overview
Table 86. BD Antiviral Drug Resistance Product
Table 87. BD Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 88. BD Recent Development
Table 89. F. Hoffmann-La Roche Ltd. Company Detail
Table 90. F. Hoffmann-La Roche Ltd. Business Overview
Table 91. F. Hoffmann-La Roche Ltd. Antiviral Drug Resistance Product
Table 92. F. Hoffmann-La Roche Ltd. Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 93. F. Hoffmann-La Roche Ltd. Recent Development
Table 94. Trinity Biotech Company Detail
Table 95. Trinity Biotech Business Overview
Table 96. Trinity Biotech Antiviral Drug Resistance Product
Table 97. Trinity Biotech Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 98. Trinity Biotech Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiviral Drug Resistance Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Antiviral Drug Resistance Market Share by Type: 2023 VS 2030
Figure 3. Immunodiagnostics Features
Figure 4. Polymerase Chain Reaction (PCR) Features
Figure 5. Next Generation Sequencing (NGS) Features
Figure 6. Sanger Sequencing Features
Figure 7. Other Technologies Features
Figure 8. Global Antiviral Drug Resistance Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Antiviral Drug Resistance Market Share by Application: 2023 VS 2030
Figure 10. Hospitals & Clinics Case Studies
Figure 11. Pathology or Diagnostic Laboratories Case Studies
Figure 12. Research Institutes Case Studies
Figure 13. Others Case Studies
Figure 14. Antiviral Drug Resistance Report Years Considered
Figure 15. Global Antiviral Drug Resistance Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Antiviral Drug Resistance Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Antiviral Drug Resistance Market Share by Region: 2023 VS 2030
Figure 18. Global Antiviral Drug Resistance Market Share by Players in 2023
Figure 19. Global Top Antiviral Drug Resistance Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Drug Resistance as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Antiviral Drug Resistance Revenue in 2023
Figure 21. North America Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Antiviral Drug Resistance Market Share by Country (2019-2030)
Figure 23. United States Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Antiviral Drug Resistance Market Share by Country (2019-2030)
Figure 27. Germany Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Antiviral Drug Resistance Market Share by Region (2019-2030)
Figure 35. China Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Antiviral Drug Resistance Market Share by Country (2019-2030)
Figure 43. Mexico Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Antiviral Drug Resistance Market Share by Country (2019-2030)
Figure 47. Turkey Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. AccuBioTech Co., Ltd. Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 50. ACON Laboratories, Inc. Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 51. Siemens AG Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 52. BioMerieux SA Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 53. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 54. Danaher Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 55. Abbott Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 56. BD Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 57. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 58. Trinity Biotech Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Antiviral Drug Resistance Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Immunodiagnostics
Table 3. Key Players of Polymerase Chain Reaction (PCR)
Table 4. Key Players of Next Generation Sequencing (NGS)
Table 5. Key Players of Sanger Sequencing
Table 6. Key Players of Other Technologies
Table 7. Global Antiviral Drug Resistance Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Antiviral Drug Resistance Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Antiviral Drug Resistance Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Antiviral Drug Resistance Market Share by Region (2019-2024)
Table 11. Global Antiviral Drug Resistance Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Antiviral Drug Resistance Market Share by Region (2025-2030)
Table 13. Antiviral Drug Resistance Market Trends
Table 14. Antiviral Drug Resistance Market Drivers
Table 15. Antiviral Drug Resistance Market Challenges
Table 16. Antiviral Drug Resistance Market Restraints
Table 17. Global Antiviral Drug Resistance Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Antiviral Drug Resistance Market Share by Players (2019-2024)
Table 19. Global Top Antiviral Drug Resistance Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Drug Resistance as of 2023)
Table 20. Ranking of Global Top Antiviral Drug Resistance Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Antiviral Drug Resistance Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Antiviral Drug Resistance Product Solution and Service
Table 24. Date of Enter into Antiviral Drug Resistance Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Antiviral Drug Resistance Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Antiviral Drug Resistance Revenue Market Share by Type (2019-2024)
Table 28. Global Antiviral Drug Resistance Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Antiviral Drug Resistance Revenue Market Share by Type (2025-2030)
Table 30. Global Antiviral Drug Resistance Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Antiviral Drug Resistance Revenue Market Share by Application (2019-2024)
Table 32. Global Antiviral Drug Resistance Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Antiviral Drug Resistance Revenue Market Share by Application (2025-2030)
Table 34. North America Antiviral Drug Resistance Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Antiviral Drug Resistance Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Antiviral Drug Resistance Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Antiviral Drug Resistance Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Antiviral Drug Resistance Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Antiviral Drug Resistance Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Antiviral Drug Resistance Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Antiviral Drug Resistance Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Antiviral Drug Resistance Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Antiviral Drug Resistance Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Antiviral Drug Resistance Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Antiviral Drug Resistance Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Antiviral Drug Resistance Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Antiviral Drug Resistance Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Antiviral Drug Resistance Market Size by Country (2025-2030) & (US$ Million)
Table 49. AccuBioTech Co., Ltd. Company Detail
Table 50. AccuBioTech Co., Ltd. Business Overview
Table 51. AccuBioTech Co., Ltd. Antiviral Drug Resistance Product
Table 52. AccuBioTech Co., Ltd. Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 53. AccuBioTech Co., Ltd. Recent Development
Table 54. ACON Laboratories, Inc. Company Detail
Table 55. ACON Laboratories, Inc. Business Overview
Table 56. ACON Laboratories, Inc. Antiviral Drug Resistance Product
Table 57. ACON Laboratories, Inc. Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 58. ACON Laboratories, Inc. Recent Development
Table 59. Siemens AG Company Detail
Table 60. Siemens AG Business Overview
Table 61. Siemens AG Antiviral Drug Resistance Product
Table 62. Siemens AG Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 63. Siemens AG Recent Development
Table 64. BioMerieux SA Company Detail
Table 65. BioMerieux SA Business Overview
Table 66. BioMerieux SA Antiviral Drug Resistance Product
Table 67. BioMerieux SA Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 68. BioMerieux SA Recent Development
Table 69. Bio-Rad Laboratories, Inc. Company Detail
Table 70. Bio-Rad Laboratories, Inc. Business Overview
Table 71. Bio-Rad Laboratories, Inc. Antiviral Drug Resistance Product
Table 72. Bio-Rad Laboratories, Inc. Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 73. Bio-Rad Laboratories, Inc. Recent Development
Table 74. Danaher Company Detail
Table 75. Danaher Business Overview
Table 76. Danaher Antiviral Drug Resistance Product
Table 77. Danaher Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 78. Danaher Recent Development
Table 79. Abbott Company Detail
Table 80. Abbott Business Overview
Table 81. Abbott Antiviral Drug Resistance Product
Table 82. Abbott Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 83. Abbott Recent Development
Table 84. BD Company Detail
Table 85. BD Business Overview
Table 86. BD Antiviral Drug Resistance Product
Table 87. BD Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 88. BD Recent Development
Table 89. F. Hoffmann-La Roche Ltd. Company Detail
Table 90. F. Hoffmann-La Roche Ltd. Business Overview
Table 91. F. Hoffmann-La Roche Ltd. Antiviral Drug Resistance Product
Table 92. F. Hoffmann-La Roche Ltd. Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 93. F. Hoffmann-La Roche Ltd. Recent Development
Table 94. Trinity Biotech Company Detail
Table 95. Trinity Biotech Business Overview
Table 96. Trinity Biotech Antiviral Drug Resistance Product
Table 97. Trinity Biotech Revenue in Antiviral Drug Resistance Business (2019-2024) & (US$ Million)
Table 98. Trinity Biotech Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiviral Drug Resistance Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Antiviral Drug Resistance Market Share by Type: 2023 VS 2030
Figure 3. Immunodiagnostics Features
Figure 4. Polymerase Chain Reaction (PCR) Features
Figure 5. Next Generation Sequencing (NGS) Features
Figure 6. Sanger Sequencing Features
Figure 7. Other Technologies Features
Figure 8. Global Antiviral Drug Resistance Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Antiviral Drug Resistance Market Share by Application: 2023 VS 2030
Figure 10. Hospitals & Clinics Case Studies
Figure 11. Pathology or Diagnostic Laboratories Case Studies
Figure 12. Research Institutes Case Studies
Figure 13. Others Case Studies
Figure 14. Antiviral Drug Resistance Report Years Considered
Figure 15. Global Antiviral Drug Resistance Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Antiviral Drug Resistance Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Antiviral Drug Resistance Market Share by Region: 2023 VS 2030
Figure 18. Global Antiviral Drug Resistance Market Share by Players in 2023
Figure 19. Global Top Antiviral Drug Resistance Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Drug Resistance as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Antiviral Drug Resistance Revenue in 2023
Figure 21. North America Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Antiviral Drug Resistance Market Share by Country (2019-2030)
Figure 23. United States Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Antiviral Drug Resistance Market Share by Country (2019-2030)
Figure 27. Germany Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Antiviral Drug Resistance Market Share by Region (2019-2030)
Figure 35. China Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Antiviral Drug Resistance Market Share by Country (2019-2030)
Figure 43. Mexico Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Antiviral Drug Resistance Market Share by Country (2019-2030)
Figure 47. Turkey Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Antiviral Drug Resistance Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. AccuBioTech Co., Ltd. Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 50. ACON Laboratories, Inc. Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 51. Siemens AG Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 52. BioMerieux SA Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 53. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 54. Danaher Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 55. Abbott Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 56. BD Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 57. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 58. Trinity Biotech Revenue Growth Rate in Antiviral Drug Resistance Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232